Kamikubo K, Murase H, Niwa M, Miura K, Miura Y, Satoh T, Tomita A, Nakamura S, Miyashita T, Imai T
Dept. of Med., Gero Hot Spring Hospital, Gifu, Japan.
NIDA Res Monogr. 1986;75:133-6.
The expression of opioid receptors and GTP-binding proteins was studied in 14 pheochromocytomas. The amounts of [3H]diprenorphine bound to membranes varied from 13 to 62 fmole/mg protein, but significantly higher in adrenaline-secreting tumors than in noradrenaline-secreting tumors. None of [3H]DADLE, [125I]beta-endorphin or [3H]ethylketocyclazocine binding was correlated with [3H]diprenorphine binding. Gpp(NH)p inhibition of [3H]DADLE binding was evident in all four normal human adrenal medullae but in only 8 out of 14 pheochromocytomas. The extent of Gpp(NH)p inhibition was not correlated with the amount of pertussis toxin (PT)-sensitive GTP-binding proteins as measured by PT-catalyzed [32P]ADP-ribosylation. The present findings suggest that opioid receptors and PT-sensitive GTP-binding proteins are variously expressed in transformed chromaffin cells, pheochromocytoma.
在14例嗜铬细胞瘤中研究了阿片受体和GTP结合蛋白的表达。与膜结合的[3H]二丙诺啡量在13至62飞摩尔/毫克蛋白之间变化,但在分泌肾上腺素的肿瘤中显著高于分泌去甲肾上腺素的肿瘤。[3H]DADLE、[125I]β-内啡肽或[3H]乙基酮环唑新的结合均与[3H]二丙诺啡结合无关。Gpp(NH)p对[3H]DADLE结合的抑制在所有四个正常人类肾上腺髓质中均明显,但在14例嗜铬细胞瘤中仅8例出现。Gpp(NH)p抑制程度与通过百日咳毒素(PT)催化的[32P]ADP核糖基化测定的PT敏感GTP结合蛋白量无关。目前的研究结果表明,阿片受体和PT敏感GTP结合蛋白在转化的嗜铬细胞即嗜铬细胞瘤中存在不同表达。